Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

The Fred Hutchinson Cancer Center recently added irreversible electroporation (IRE) to its slate of focal therapy offerings and is the only cancer center in the region to offer IRE, high-intensity ...

Metastatic prostate cancer is cancer that began in the prostate but has spread to other parts of the body. There's no cure, but there are a number of effective treatments you can discuss with a ...

Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.

LOS ANGELES (KABC) -- Stage 4 prostate cancer patients can benefit the most from a triple combination therapy, studies show. But doctors say the most essential part of treating men with this dire ...

Cancer treatment is moving toward more targeted therapy, treating the malignancy without damaging healthy tissue. Now, that approach is aimed at prostate cancer, with a device already in use for other ...

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation ...

Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...

AtlantiCare recently announced it was the first health care provider in South Jersey to offer “the next evolution” in prostate care. According to the Egg Harbor-based provider, Aquablation therapy ...

Researchers and clinicians from six leading medical centers and academic institutions—including the University of California San Diego—have collaborated to develop a new artificial intelligence model ...

Longitudinal PRO modeling, rather than time-to-worsening censoring, indicated maintained HRQOL and pain outcomes with ...